Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nyxoah S A (NQ: NYXH )

9.550 +0.150 (+1.60%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Nyxoah S A

< Previous 1 2 3 Next >
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024
From Nyxoah
Via GlobeNewswire
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Nyxoah Raises $27 Million through its At-the-Market Offering
From Nyxoah
Via GlobeNewswire
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
From Nyxoah
Via GlobeNewswire
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Nyxoah to Participate in Upcoming Investor Conferences
From Nyxoah
Via GlobeNewswire
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
From Nyxoah
Via GlobeNewswire
Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results
From Nyxoah
Via GlobeNewswire
Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024
From Nyxoah
Via GlobeNewswire
Nyxoah Appoints Scott Holstine as Chief Commercial Officer
From Nyxoah
Via GlobeNewswire
Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank
From Nyxoah
Via GlobeNewswire
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA
From Nyxoah
Via GlobeNewswire
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Nyxoah to Participate in the Jefferies Global Healthcare Conference
From Nyxoah
Via GlobeNewswire
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
From Nyxoah
Via GlobeNewswire
Information on the Total Number of Voting Rights and Shares
From Nyxoah
Via GlobeNewswire
Nyxoah Announces Pricing of Offering
From Nyxoah
Via GlobeNewswire
Nyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering Program
From Nyxoah
Via GlobeNewswire
Nyxoah Announces Proposed Offering of Ordinary Shares
From Nyxoah
Via GlobeNewswire
Nyxoah Reports First Quarter 2024 Financial and Operating Results
From Nyxoah
Via GlobeNewswire
Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024
From Nyxoah
Via GlobeNewswire
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024
From Nyxoah
Via GlobeNewswire
Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer
From Nyxoah
Via GlobeNewswire
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.